Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Clin Genitourin Cancer. 2020 Mar 29;18(4):258–267.e1. doi: 10.1016/j.clgc.2019.11.002

Figure 2. Median Overall Survival.

Figure 2.

Kaplan-Meier plots of overall survival of the total population (A) and separated by patients with or without prior docetaxel therapy (B). Median potential follow-up was 37.4 months.